AR and prostate carcinoma: Besides, the lately study elaborated that PCGEM1 and PRNCR1, bound successively to the androgen receptor and strongly enhanced both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells [46].